In many human cancers, including pancreatic cancer, constitutive activation of NF-κB has been observed and may be associated with chemotherapy resistance, including gemcitabine, and inhibition of NF-κB may be useful for enhancing sensitivity to chemotherapy in cancer therapy [20–23]. The gene discussed is NFKB1; the disease is pancreatic neoplasm.